<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The protein kinase C activator, <z:chebi fb="0" ids="8116">phorbol</z:chebi> 12-<z:chebi fb="0" ids="30807">myristate</z:chebi> 13-<z:chebi fb="49" ids="30089,47622">acetate</z:chebi> (<z:chebi fb="1" ids="53780">PMA</z:chebi>), is known to interact with aquaporin-4 (AQP4), a water-selective transporting protein abundant in astrocytes and ependymal cells, that has been found to decrease osmotically-induced swelling </plain></SENT>
<SENT sid="1" pm="."><plain>The purpose of this study was to examine whether <z:chebi fb="1" ids="53780">PMA</z:chebi> given at different time points following focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) reduces <z:hpo ids='HP_0002181'>brain edema</z:hpo> by AQP4 modulation </plain></SENT>
<SENT sid="2" pm="."><plain>Male Sprague-Dawley rats were randomly assigned to sham procedure, vehicle, or <z:chebi fb="1" ids="53780">PMA</z:chebi> infusion (230 microg/kg), starting either 60 minutes before, or 30 or 60 minutes after MCAO (each group n = 12) </plain></SENT>
<SENT sid="3" pm="."><plain>After a 2-hour period of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and 2 hours of reperfusion, the animals were sacrificed for assessment of brain water content, <z:chebi fb="199" ids="26708">sodium</z:chebi>, and <z:chebi fb="120" ids="26216">potassium</z:chebi> concentrations </plain></SENT>
<SENT sid="4" pm="."><plain>AQP4 expression was assessed by immunoblotting </plain></SENT>
<SENT sid="5" pm="."><plain>Statistical analysis was performed by ANOVA followed by Tukey's post hoc test </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="1" ids="53780">PMA</z:chebi> treatment significantly reduced brain water content concentration in the infarcted area when started before or 30 minutes post-occlusion (p &lt; 0.001, p = 0.022) and prevented the subsequent <z:chebi fb="199" ids="26708">sodium</z:chebi> shift (p &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, <z:chebi fb="1" ids="53780">PMA</z:chebi> reduced <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced AQP4 up-regulation (p &lt; 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>Attenuation of the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced AQP4 up-regulation by <z:chebi fb="1" ids="53780">PMA</z:chebi> suggests that the reduction in <z:hpo ids='HP_0002181'>brain edema</z:hpo> formation following <z:chebi fb="1" ids="53780">PMA</z:chebi> treatment was at least in part mediated by AQP4 modulation </plain></SENT>
</text></document>